approval · primary record
INSULIN GLARGINE-YFGN
FDA · BLA · 2024-11-25
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2024-11-25 |
| Brand | SEMGLEE |
| Sponsor | MYLAN PHARMS INC |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:40.994Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:INSULIN GLARGINE-YFGN:2024-11-25
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.